Can denervating the pulmonary artery reduce heart-failure events? Pulnovo begins pivotal US test
Pulnovo has treated the first two US patients in PULSE-LHD, a randomized 750-patient IDE study testing whether pulmonary artery denervation can reduce major heart-failure events in combined pre- and post-capillary pulmonary hypertension.
